98%
921
2 minutes
20
Objectives: Some psychotropic medications could impair drivers' cognitive skills, concentration and reaction by affecting the central nervous system (CNS), thereby increasing the risk of traffic accidents. However, there is limited evidence regarding the prescription pattern of these medications in Iran. The present study aims to investigate the prescription pattern of psychotropic medications impairing driving in Tabriz, Iran.
Methods: In this descriptive-analytical cross-sectional study, psychotropic medications prescribed by physicians in Tabriz from March, 2021, to March, 2022, were reviewed. The data were obtained from Iranian Social Security Organization (SSO), which included 1,167,460 eligible prescriptions. Psychotropic medications were classified into six main categories based on reliable scientific sources, and their level of effect on driving was determined using driving-impairing medication classification system. The data were analyzed using Stata 17.0 and Chi-square test. The significance level was considered to be less than 0.05.
Results: The results showed out of 1,167,460 prescribed psychotropic medications, 65.32% were for women, and the rest were for men. The most frequently prescribed medications were antidepressants (38.07%), followed by anxiolytics (18.60%) and antipsychotics (15.48%), respectively. More than half of the medications (57.10%) was categorized to have moderate effect, 23.73% was categorized to have mild effect and 18.87% was categorized to have severe effect on driving. Gabapentin, sertraline, nortriptyline, fluoxetine and trifluoperazine were the most frequently prescribed medications, respectively. A significant correlation was observed between the impairment category of prescribed medications and patients' gender and age ( <0.001). Additionally, general practitioners prescribed the highest number of medications with severe adverse effects, while neurosurgeons, general surgeons, neurologists and psychiatrists prescribed the highest number of medications with moderate adverse effects on driving.
Conclusions: More than half of the prescribed psychotropic medications in Tabriz was categorized to have moderate effects on driving, and about one-fifth was categorized to have severe effects. Antidepressants, anxiolytics and antipsychotics are considered to have the most relevant impairing effects on driving according to the categorization system, with gabapentin, sertraline, nortriptyline, fluoxetine and trifluoperazine being the most frequently prescribed medications. The findings highlighted the importance of raising awareness among physicians and patients about the effects of psychotropic medications on driving.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/15389588.2025.2484224 | DOI Listing |
JAMA Pediatr
September 2025
Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York.
Vestn Oftalmol
September 2025
OOO Diagnosticheskij tsentr Zreniye, Saint Petersburg, Russia.
Objective: This study evaluated the effect of sequential therapy with different dosages of Mexidol on the stabilization of glaucomatous optic neuropathy (GON) in patients with primary open-angle glaucoma (POAG).
Material And Methods: The study included 80 patients (160 eyes) with stage II and III POAG, randomized into three groups comparable by age, gender, and distribution of glaucoma stage. All patients received sequential therapy with Mexidol (14 days parenterally followed by 90 days orally).
Drug Dev Res
September 2025
Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics, School of Pharmacy, Tianjin Medical University, Tianjin, P. R. China.
The structural modification and derivatization of natural products represent an essential pathway for pharmaceutical innovation in the management of depression. The 8-phenyl tetrahydroisoquinoline, as a parent core, was obtained from magnoflorine by a structural simplification strategy. The present report details the synthesis and antidepressant activity studies of 8-phenyl-THIQ analogs.
View Article and Find Full Text PDFBiol Psychiatry Glob Open Sci
November 2025
Brain and Mind Centre, The University of Sydney, Sydney, New South Wales, Australia.
Background: Neuroimmune processes are often implicated in young people with atypical neuropsychiatric disorders, yet treatment implications remain controversial. This case series details young people with primary psychiatric disorders who received adjunctive immunotherapy after thorough investigation and extensive conventional treatments.
Methods: We evaluated 45 individuals (93% female, ages 12-30 years) with atypical psychiatric presentations suggesting potential neuroimmune involvement.
Depress Anxiety
September 2025
Medical Imaging Center, First Affiliated Hospital of Jinan University, Guangzhou, China.
The therapeutic effects of vortioxetine on mood and cognition have been documented in major depressive disorder (MDD). This study aims to examine whether vortioxetine can improve brain glymphatic system function and connections among functional brain networks and to explore the underlying relationships among these changes. A total of 34 patients with MDD and 41 healthy controls (HCs) were recruited in the study.
View Article and Find Full Text PDF